Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-104.08M
↓ 40% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-74.14M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-104.08M | -29.6% |
| 2024 | $-80.28M | +46.5% |
| 2023 | $-150.08M | -36.6% |
| 2022 | $-109.90M | -94.4% |
| 2021 | $-56.54M | -316.3% |
| 2020 | $-13.58M | -200.8% |
| 2019 | $-4.51M | - |